Presence of Somatic Mutations within PIK3CA, AKT, RAS, and FGFR3 but not BRAF in Cisplatin-Resistant Germ Cell Tumors von FELDMAN, Darren R, IYER, Gopa, VAN ALSTINE, Lindsay, PATIL, Sujata, AI-AHMADIE, Hikmat, REUTER, Victor E, BOSL, George J, CHAGANTI, Raju S, SOLIT, David B

Volltext

Serum tumor marker (STM) decline rates during high-dose chemotherapy (HDCT) to predict outcome for germ cell tumor (GCT) patients (pts) von Feldman, Darren Richard, Voss, Martin Henner, Jia, Xiaoyu, Van Alstine, Lindsay Joy, Patil, Sujata, Fischer, Patricia, Sheinfeld, Joel, Bosl, George J., Motzer, Robert John

Volltext

Phase I/II study of paclitaxel plus ifosfamide (TI) followed by high-dose paclitaxel, ifosfamide, and carboplatin (TIC) with autologous stem cell transplant (ASCT) for salvage trea... von Jia, Xiaoyu, Feldman, Darren Richard, Glezerman, Ilya, Van Alstine, Lindsay Joy, Bajorin, Dean F., Fischer, Patricia, Hughes, Amanda, Sheinfeld, Joel, Bains, Manjit S., Reich, Lilian, Bosl, George J., Motzer, Robert John, Patil, Sujata

Volltext

Phase I/II Trial of Paclitaxel With Ifosfamide Followed by High-Dose Paclitaxel, Ifosfamide, and Carboplatin (TI-TIC) With Autologous Stem Cell Reinfusion for Salvage Treatment of ... von Feldman, Darren R, Glezerman, Ilya, Patil, Sujata, Van Alstine, Lindsay, Bajorin, Dean F, Fischer, Patricia, Hughes, Amanad, Sheinfeld, Joel, Bains, Manjit, Reich, Lilian, Woo, Kaitlin, Giralt, Sergio, Bosl, George J, Motzer, Robert J

Volltext

Paclitaxel, ifosfamide, and cisplatin (TIP) efficacy for first-line treatment of patients (pts) with intermediate- or poor-risk germ cell tumors (GCT) von Feldman, Darren Richard, Hu, James, Dorff, Tanya B., Patil, Sujata, Van Alstine, Lindsay Joy, Momen, Lamia, Carousso, Maryann, Hughes, Amanda, Snively-Solomon, Jolie, Ketchens, Charlean, Sheinfeld, Joel, Bains, Manjit S., Bajorin, Dean F., Bosl, George J., Motzer, Robert John, Quinn, David I.

Volltext

Phase II trial of paclitaxel, ifosfamide, and cisplatin (TIP) for previously untreated patients (pts) with intermediate- or poor-risk germ cell tumors (GCT) von Feldman, Darren Richard, Hu, James, Dorff, Tanya B., Patil, Sujata, Van Alstine, Lindsay Joy, Momen, Lamia, Carousso, Maryann, Hughes, Amanda, Snively-Solomon, Jolie, Ketchens, Charlean, Sheinfeld, Joel, Bains, Manjit S., Bajorin, Dean F., Bosl, George J., Motzer, Robert John, Quinn, David I.

Volltext

Phase I/II Trial of Paclitaxel Plus Ifosfamide Followed by High-Dose Paclitaxel, Ifosfamide, and Carboplatin (TI-TIC) with Autologous Stem Cell Reinfusion for Salvage Treatment of... von Feldman, Darren R., Glezerman, Ilya, Patil, Sujata, Van Alstine, Lindsay, Bajorin, Dean F., Fischer, Patricia, Hughes, Amanad, Sheinfeld, Joel, Bains, Manjit, Reich, Lilian, Woo, Kaitlin, Giralt, Sergio, Bosl, George J., Motzer, Robert J.

Volltext

Phase I/II Study of Paclitaxel Plus Ifosfamide Followed By High-Dose Paclitaxel, Ifosfamide, and Carboplatin with Autologous Stem Cell Reinfusion for Salvage Treatment of Germ Cell... von Feldman, Darren R., MD, Glezerman, Ilya, MD, Patil, Sujata, PhD, Van Alstine, Lindsay, Bajorin, Dean F., MD, Fischer, Patricia, Hughes, Amanda, Sheinfeld, Joel, Bains, Manjit, Reich, Lilian, MD, PhD, Bosl, George J., MD, Giralt, Sergio A., MD, Motzer, Robert J., MD

Volltext